2013. Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2 , 136-140.

(2013). Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, 136-140.

. "Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model," INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, 136-140, 2013

"Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model." INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, pp.136-140, 2013

(2013) . "Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model." INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, pp.136-140.

@article{article, title={Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model}, journal={INTERNATIONAL JOURNAL OF OPHTHALMOLOGY}, year=2013, pages={136-140} }